EP4152948A4 - Immun-priming zur beschleunigung/verstärkung einer immunantwort durch verabreichung eines natürlichen immunmodulators - Google Patents

Immun-priming zur beschleunigung/verstärkung einer immunantwort durch verabreichung eines natürlichen immunmodulators Download PDF

Info

Publication number
EP4152948A4
EP4152948A4 EP21828842.1A EP21828842A EP4152948A4 EP 4152948 A4 EP4152948 A4 EP 4152948A4 EP 21828842 A EP21828842 A EP 21828842A EP 4152948 A4 EP4152948 A4 EP 4152948A4
Authority
EP
European Patent Office
Prior art keywords
immune
administrating
accelerate
enhance
priming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21828842.1A
Other languages
English (en)
French (fr)
Other versions
EP4152948A1 (de
Inventor
Amy E. Steffek
Andrew A. Dahl
William P. Pfund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zivo Bioscience Inc
Original Assignee
Zivo Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zivo Bioscience Inc filed Critical Zivo Bioscience Inc
Priority claimed from PCT/US2021/039180 external-priority patent/WO2021263162A1/en
Publication of EP4152948A1 publication Critical patent/EP4152948A1/de
Publication of EP4152948A4 publication Critical patent/EP4152948A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP21828842.1A 2020-06-26 2021-06-25 Immun-priming zur beschleunigung/verstärkung einer immunantwort durch verabreichung eines natürlichen immunmodulators Pending EP4152948A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063044841P 2020-06-26 2020-06-26
PCT/US2021/039180 WO2021263162A1 (en) 2020-06-26 2021-06-25 Immune priming to accelerate/enhance immune response through administration of natural immune modulator

Publications (2)

Publication Number Publication Date
EP4152948A1 EP4152948A1 (de) 2023-03-29
EP4152948A4 true EP4152948A4 (de) 2024-08-07

Family

ID=85279331

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21828842.1A Pending EP4152948A4 (de) 2020-06-26 2021-06-25 Immun-priming zur beschleunigung/verstärkung einer immunantwort durch verabreichung eines natürlichen immunmodulators

Country Status (2)

Country Link
EP (1) EP4152948A4 (de)
CN (1) CN116075317A (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082908B1 (de) * 1999-03-26 2009-08-26 Genichiro Soma Zusaetze fuer krustentier- bzw. fischfuttermittel sowie futtermittel
US20140194287A1 (en) * 2011-06-14 2014-07-10 Gen-Ichiro Soma Crushed bacterial body and compositions thereof
US10017727B2 (en) * 2005-11-28 2018-07-10 Gen-Ichiro Soma Method for fermentation and culture, fermented plant extract, fermented plant extract composition, method for producing lipopolysaccharide and lipopolysaccharide
WO2021231869A1 (en) * 2020-05-14 2021-11-18 Zivo Bioscience, Inc. Use of tlr4 modulator in the treatment of coccidiosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2109254T3 (es) * 1985-12-03 1998-01-16 Dimminaco Ag Sa Ltd Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
EP1260227A1 (de) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichonsäure aus Milchsäurebakterien sowie dessen Verwendung zur Modulierung der durch gram-negative, potenziell pathogene gram-positive Bakterien induzierte Immunantwort
US10632157B2 (en) * 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
US11806375B2 (en) * 2016-02-16 2023-11-07 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082908B1 (de) * 1999-03-26 2009-08-26 Genichiro Soma Zusaetze fuer krustentier- bzw. fischfuttermittel sowie futtermittel
US10017727B2 (en) * 2005-11-28 2018-07-10 Gen-Ichiro Soma Method for fermentation and culture, fermented plant extract, fermented plant extract composition, method for producing lipopolysaccharide and lipopolysaccharide
US20140194287A1 (en) * 2011-06-14 2014-07-10 Gen-Ichiro Soma Crushed bacterial body and compositions thereof
WO2021231869A1 (en) * 2020-05-14 2021-11-18 Zivo Bioscience, Inc. Use of tlr4 modulator in the treatment of coccidiosis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "ZIVO Bioscience Announces Impressive Long-Term Benefits for Broiler Poultry Nutrition and Growth Promotion", 18 March 2020 (2020-03-18), XP093134996, Retrieved from the Internet <URL:https://www.zivobioscience.com/news-media/press-releases/detail/49/zivo-bioscience-announces-impressive-long-term-benefits-for> [retrieved on 20240226] *
BENJAMIN A L ET AL: "Neonatal lipopolysaccharide exposure does not diminish the innate immune response to a subsequent lipopolysaccharide challenge in Holstein bull calves", JOURNAL OF DAIRY SCIENCE, vol. 99, no. 7, 20 April 2016 (2016-04-20), pages 5750 - 5763, XP029602013, ISSN: 0022-0302, DOI: 10.3168/JDS.2015-10804 *
R LEVINE ET AL: "Evaluation of the effects of feeding dried algae containing beta-1,3-glucan on broilers challenged with Eimeria", POULTRY SCIENCE, vol. 97, no. 10, 1 October 2018 (2018-10-01), Oxford, pages 3494 - 3500, XP055722067, ISSN: 0032-5791, DOI: 10.3382/ps/pey227 *
See also references of WO2021263162A1 *

Also Published As

Publication number Publication date
EP4152948A1 (de) 2023-03-29
CN116075317A (zh) 2023-05-05

Similar Documents

Publication Publication Date Title
EP4008007C0 (de) Gruppierung von angepassten segmenten zur bestimmung der verknüpfung eines datensatzes in einer datenbank
EP3813722C0 (de) Bereitstellung eines simulierten ergebnisses der zahnbehandlung an einem patienten
EP3830810C0 (de) Flugtrainingssimulation mit anzeige einer virtuellen umgebung
EP3674870C0 (de) Lernen eines neuronalen netzwerks zur ableitung von editierbaren merkmalsbäumen
PY1562426A (es) Moléculas de ácido nucléico de subunidad copi coatomer alfa que confieren una resistencia a plagas de coleópteros y hemípteros
EP3814741A4 (de) Herstellung eines zusammengesetzten bildes einer gefärbten gewebeprobe durch kombinieren von bilddaten
EP3899149C0 (de) Koppler zur kopplung eines aufsatzes an einen kellenarm
DK3527163T3 (da) Computerimplementeret fremgangsmåde til at modificere en digital tredimensionel model af en dentition
EP3630144A4 (de) Neue onkolytische viren zur sensibilisierung von tumorzellen für abtötung durch natürliche killerzellen
EP4094523C0 (de) Netzwerkunterstützte selbstmessungen zur ermöglichung eines vollduplex-betriebes
EP3724845A4 (de) Software-rahmen zur fortschrittsverfolgung in einer klassenzimmersituation
EP3750121C0 (de) Computer-implementiertes verfahren zum trainieren von einer vielzahl von computern
IL278538B1 (en) Compositions and methods concerning immune tolerance
EP3755210C0 (de) Anpassung von medieninhalt an einen erfassten zustand eines benutzers
EP3755140C0 (de) Vorrichtung zur modularen vegetation eines gebäudes
EP3994117C0 (de) Hydrierung von estern zu alkoholen in gegenwart eines ru-pnn-komplexes
EP4046004C0 (de) Erzeugung eines 3d-modells eines anlagenlayouts
EP4041208A4 (de) Zusammensetzungen von cannabinoiden zur verabreichung durch inhalation
EP4178544A4 (de) Nukleosidmodifizierte rna zur induktion einer immunreaktion gegen sars-cov-2
EP4113224C0 (de) Mensch-maschine-schnittstelle mit erweiterter realität zur simulation der tatsächlichen strömung
BR112019007073A2 (pt) extrato de planta embebido em alulose e método de preparação
CO2018011291A2 (es) Métodos para mejorar el crecimiento y la tolerancia al estrés en plantas
DE112016001112A5 (de) Verfahren zur Adaption eines Kupplungsmodells einer automatisierten Kupplung durch Anpassung eines Reibwertes der Kupplung
EP3781690A4 (de) Manipulierte biosynthesewege zur herstellung von histamin durch fermentation
Sosa et al. Okadaic acid and other diarrheic toxins: Toxicological profile

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240705

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/09 20060101ALI20240701BHEP

Ipc: C07K 14/455 20060101ALI20240701BHEP

Ipc: A61P 33/02 20060101ALI20240701BHEP

Ipc: A61K 39/012 20060101ALI20240701BHEP

Ipc: A61K 39/00 20060101ALI20240701BHEP

Ipc: A23K 50/75 20160101ALI20240701BHEP

Ipc: A61K 31/739 20060101AFI20240701BHEP